| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |